Video

Dr. Parikh Discusses Liquid Biopsies in Gastrointestinal Cancers

Aparna R. Parikh, MD, medical oncologist, Massachusetts General Hospital, discusses liquid biopsies in gastrointestinal cancers.

Aparna R. Parikh, MD, medical oncologist, Massachusetts General Hospital, discusses liquid biopsies in gastrointestinal (GI) cancers.

In an effort to better understand acquired resistance to targeted therapies in GI cancers, investigators collected plasma via liquid biopsy at disease progression for next-generation sequencing of circulating tumor DNA.

Tissue biopsies may not capture the entirety of the tumor in terms of heterogeneity, says Parikh.

<<<

View more from the 2017 World Congress on GI Cancer

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Related Videos
Paul G. Richardson, MD
Kevin Kalinsky, MD, MS, discusses the potential to switch CDK4/6 inhibitors in HR-positive metastatic breast cancer.
Dr Tolaney on Considerations for Adjuvant CDK4/6 Inhibitors in HR+/HER2-Negative Breast Cancer
Dr Jagsi on Factors for RT Omission After Breast-Conserving Surgery in Early Breast Cancer
Dr Borgen on the Need for Improved Risk Stratification in Early-Stage Breast Cancer
Richard T. Lee, MD, Cherng Family Director’s Chair, Center for Integrative Oncology, medical director, clinical professor, Supportive & Integrative Medicine, Department of Supportive Care Medicine, City of Hope
Rachna T. Shroff, MD, MS
Dr Coombs on the Challenges in Establishing a Treatment Consensus for Relapsed CLL
Daneng Li, MD, associate professor, Department of Medical Oncology & Therapeutics Research, and co-director, Neuroendocrine Tumor Program, City of Hope
Dr Janjigian on 5-Year Data With Nivolumab Plus Chemotherapy in Gastric/GEJ/Esophageal Cancer